Epsilogen Ltd Alternatives & Competitors
12 companies similar to Epsilogen Ltd — Harnessing the power of IgE
Companies similar to Epsilogen Ltd
Hercules Pharmaceuticals
Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...
Houston, United States
Seneca Therapeutics, Inc.
Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for...
Philadelphia, United Stat...
Rival Readout
Competing with Epsilogen Ltd? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Tarveda Therapeutics
To discover, develop and commercialize a new class of potent and selective precision oncol...
Watertown, United States
Umoja Biopharma
Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...
Cytovation
Creating transformative medicines for patients with cancer
Bergen, Norway
CatalYm GmbH
Developing innovative immunotherapies to transform cancer patients’ lives by engaging thei...
Germany
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
About Epsilogen Ltd
Epsilogen is a biopharmaceutical startup based in the United Kingdom, founded in 2016. The company is focused on harnessing the power of IgE antibodies for cancer treatment, aiming to address solid tumors with greater potency, enhanced access, and a long tissue half-life. Epsilogen's lead program targets the folate rec...
Cancer Treatment, Immunoglobulin Antibodies, IgE Therapy, Solid Tumors, Oncology, Phase I Trial, Folate Receptor Alpha, Anti-cancer Drugs, Clinical Development, Global Leader, Immunotherapy, Tumor Targeting, Immune Response, Clinical Trials, Biopharmaceutical
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Epsilogen Ltd: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Epsilogen Ltd on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
